Background-Inbred mouse strains C57BL/6J (B6) and C3H/HeJ (C3H) exhibit marked differences in neointimal formation after arterial injury when deficient in apolipoprotein E (apoE Ϫ/Ϫ ) and fed a Western diet. Quantitative trait locus analysis was performed on an intercross between B6.apoE Ϫ/Ϫ and C3H.apoE Ϫ/Ϫ mice to determine genetic factors contributing to the phenotype. Methods and Results-Female B6.apoE Ϫ/Ϫ mice were crossed with male C3H.apoE Ϫ/Ϫ mice to generate F 1 s, which were intercrossed to generate 204 male F 2 progeny. At 10 weeks of age, F 2 s underwent endothelium denudation injury to the left common carotid artery. Mice were fed a Western diet for 1 week before and 4 weeks after injury and analyzed for neointimal lesion size, plasma lipid, and membrane cofactor protein (MCP)-1 levels. One significant quantitative trait locus, named Nih1 (61 cM; LOD score, 5.02), on chromosome 12 and a suggestive locus on chromosome 13 (35 cM; LOD score, 2.67) were identified to influence lesion size. One significant quantitative trait locus on distal chromosome 1 accounted for major variations in plasma non-high-density lipoprotein cholesterol and triglyceride levels. Four suggestive quantitative trait locis on chromosomes 1, 2, and 3 were detected for circulating MCP-1 levels. No correlations were observed between neointimal lesion size and plasma lipid levels or between lesion size and plasma MCP-1 levels. Conclusions-Neointimal formation is controlled by genetic factors independent of those affecting plasma lipid levels and circulating MCP-1 levels in the B6 and C3H mouse model. (Circ Cardiovasc Genet. 2009;2:220-228.)
R estenosis remains the most significant challenge limiting the success of angioplasty treatment to atherosclerotic cardiovascular disease. The incidence of restenosis after arterial interventions varies from 10% to 80% within 6 months, depending on the location of treatment and the type of intervention. 1 The placement of intravascular stents has proven effective in reducing postinterventional restenosis, but a fraction of patients receiving stents develop late in-stent restenosis. Neointimal hyperplasia is the primary cause for in-stent restenosis. 2 
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Accumulating evidence indicates that restenosis is not a random phenomenon but a multifactorial disorder with a strong heritable component. [3] [4] [5] [6] Association studies have revealed an array of genes to be potentially involved in the restenotic process. 5, [7] [8] [9] However, the results should be interpreted with caution because of small sample sizes and the heterogeneity of the patients. The difficulties inherent in human genetic studies strongly suggest that parallel approaches should be undertaken to identify genes for neointimal formation by using animal models.
The availability of numerous inbred mouse strains that differ in injury-induced neointimal thickening provides an experimental tool for identifying genetic factors involved in the restenostic process. C57BL/6 (B6) and C3H mice are 2 inbred strains that exhibit dramatic differences in neointimal formation when deficient in apolipoprotein E (apoE Ϫ/Ϫ ) and fed a Western diet. 10 B6.apoE Ϫ/Ϫ mice readily develop neointimal lesions following carotid arterial endothelium denudation injury, whereas C3H.apoE Ϫ/Ϫ mice are almost totally resistant to lesion formation. The dramatic difference between the 2 apoE Ϫ/Ϫ strains in neointimal formation is ideal for conducting linkage analysis to dissect genetic factors contributing to the phenotype. In this study, we performed quantitative trait locus (QTL) analysis of neointimal lesions and associated traits using an intercross between B6.apoE Ϫ/Ϫ and C3H.apoE Ϫ/Ϫ mouse strains.
Methods

Mice
Female B6.apoE Ϫ/Ϫ mice were purchased from Jackson Laboratory (Bar Harbor, Me). C3H.apoE Ϫ/Ϫ mice at the N 12 generation were generated in our laboratory. Female B6.apoE Ϫ/Ϫ mice were crossed with male C3H.apoE Ϫ/Ϫ mice to generate F 1 s, which were intercrossed by brother-sister mating to generate 204 male F 2 s. Mice were weaned onto a rodent chow diet and at 9 weeks of age and were switched onto a Western diet containing 21% fat, 0.2% cholesterol, and 19.5% casein (TD 88137; Teklad, Madison, Wis) and maintained on the diet throughout the entire experiment. All procedures were carried out in accordance with the National Institutes of Health guidelines and approved by the Institutional Animal Care and Use Committee.
Endothelium Denudation
The procedure for removing the endothelium of the left common carotid artery was performed as previously described. 10, 11 Briefly, mice were anesthetized by intramuscular injection of ketamine (80 mg/kg; Aveco Inc) and xylazine (8 mg/kg; Lloyd Laboratories, Shenandoah, Iowa). Under a dissecting microscope, the left external carotid artery was ligated distally with a 6-0 silk suture and additional 6-0 sutures were looped around the common and internal carotid arteries. A transverse arteriotomy was made in the left external carotid artery, and an epon-resin probe was introduced and advanced Ϸ1 cm toward the aortic arch. Endothelial denudation of the artery was achieved by repeated withdrawal for 3 passes. After removal of the probe, the left external carotid artery was ligated and the skin incision was closed with surgical glue (Ethicon Inc, Somerville, NJ).
Plasma Lipid Measurements
Mice were fasted overnight before blood was collected through retro-orbital puncture under ketamine and xylazine anesthesia. Plasma total cholesterol, non-high-density lipoprotein (non-HDL) cholesterol, and triglyceride levels were measured with enzymatic assays as we previously described. 11
Measurements of Circulating MCP-1
The same plasma samples used for lipid analysis were assessed for circulating membrane cofactor protein (MCP)-1 levels. MCP-1 was quantified with a sandwich ELISA technique according to the manufacturer's instructions (R&D Systems, Minneapolis, MN).
Tissue Preparation and Lesion Quantification
The procedure was performed as previously described. 10, 11 Briefly, the carotid arteries were perfusion-fixed via the left ventricle with 10% formalin. After fixation in 10% formalin for more than 24 hours, the front soft tissues of the neck were dissected out, and processed by using the standard histological technique. Serial 10m-thick sections were collected, starting from the disappearance of the left common carotid artery bifurcation, and mounted on poly-Dlysine-coated slides. On average, 400 sections were collected for each mouse. All sections were subjected to van Gieson staining for elastic laminas. Morphometric measurements of the injured common carotid artery were made in every 10 sections using Image ProPlus 3.0 software (Media Cybernetics, Bethesda, MD). Luminal, internal, and external elastic areas were measured, as previously described. 12 Genotyping DNA was isolated from the tails of mice by using the standard phenol/chloroform extraction and ethanol precipitation method. A total of 125 microsatellite markers distinguishing B6 from C3H mice and covering all 19 autosomes and the X chromosome at an average interval of 13 cM were typed by polymerase chain reaction (PCR). The parental and F 1 DNA served as controls for each marker.
Statistical Analysis
Linkage analyses of neointimal lesions, plasma lipid, and MCP-1 levels were performed by using MapManager QTXb20 (http:// mapmgr.roswellpark.org) and J/qtl (http://research.jax.org/faculty/ churchill/software/Jqtl/index.html) software. The distributions of trait values in F 2 mice were assessed for normality with the SPSS program (SPSS, Chicago, Ill) by examining skewness, kurtosis, Kolmogorov-Smirnov test, and Q-Q plots. Neointimal lesion sizes were square root transformed before QTL analysis was performed as they were not normally distributed. Non-HDL cholesterol, triglyceride, and MCP-1 levels were directly used for QTL analysis. One thousand permutations of the trait values were used to define the genome-wide log-odds (LOD) score threshold required to be significant or suggestive for each specific trait. The support interval for each QTL was determined by using a 1-LOD drop from the QTL peak. Variance and mode of inheritance of the traits were determined with MapManager and further confirmation was made with linear regression analysis. ANOVA was used to determine whether the mean phenotype values of progeny with different genotypes at a specific marker were significantly different. Differences were considered statistically significant at PϽ0.05.
Candidate Gene Analysis
Sequence comparison was made to ascertain which genes within the confidence interval of Nih1 were polymorphic between B6 and C3H mice by querying the National Center for Biotechnology Information Database (http://www.ncbi.nlm.nih.gov/SNP/MouseSNP.cgi) and Mouse Phenome Database (http://www.informatics.jax.org/javawi2/ servlet/WIFetch?pageϭsnpQF). The genes containing sequence variations in coding regions leading to amino acid substitutions or in regulatory regions were further examined for their expression in the arterial wall of 2 parental strains by real-time PCR. Total RNA was exacted from the aorta and carotid arteries of 6 to 10-week-old B6.apoE Ϫ/Ϫ and C3H.apoE Ϫ/Ϫ mice fed a chow diet using Trizol, digested by DNase I, and then reverse transcribed into cDNA using the ThermoScript RT-PCR kit (Invitrogen, Carlsbad, CA). cDNA was mixed with SYBR Green supermix reagent (Bio-Rad, Boston, MA) and gene-specific primers (see online-only Data Supplement). Real-time PCR on each sample was run in triplicate on an iCycler iQ5 machine (Bio-Rad) under the condition of 50°C for 2 minutes, 95°C for 2 minutes, then 95°C 30 seconds, 60°C 30 seconds, and 72°C 30 seconds for 40 cycles. The expression of each gene was determined in 3 or 4 biologically independent samples for each strain and was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Immunohistochemical Analysis
Paraffin-embedded sections were stained with the following primary antibodies: H-196, rabbit anti-human ␣-smooth muscle actin IgG (Santa Cruz); MCA519, rat antimouse macrophage/monocyte IgG (Serotec); H-414, rabbit antihuman Yy1 IgG (Santa Cruz); and rabbit antihuman Pacs2 IgG (provided by Dr. Gary Thomas at Vollum Figure 1 . Representative cross-sections of the injured common carotid artery of B6.apoE Ϫ/Ϫ and C3H.apoE Ϫ/Ϫ mice fed a Western diet. Paraffin-embedded tissues were stained with van Gieson stain or specific antibodies against smooth muscle cells and macrophages. Note the distinct difference between the 2 strains in neointimal lesion size, the strong-actin positive arterial wall and neointimal lesions, and the focal accumulation of macrophages (arrow). Insets display magnified views of representative areas (magnification ϫ10 or ϫ20).
Institute, Portland, Ore). Sections were deparaffinized with xylene, followed by incubation with the primary antibodies. After a thorough wash, the slides were incubated with a biotinylated secondary antibody (Vector Laboratories). The reactions were visualized with a peroxidase chromogen kit (Vector Laboratories).
Sequence Analysis
The promoter region of the Yy1 gene of B6 and C3H mice was PCR-amplified using primers 5Ј-ACCTGGTCTATCGAAAGG-AAGCAC-3Ј/5Ј-TTGCCTTTACTCGTTACTCGGG-3Ј and 5Ј-TA ACGGACACACTTCCAACGGTGA-3Ј/5Ј-TCCGCGGTGCAAC-AGTGACAAA-3Ј and purified PCR products sequenced on a 3730 DNA Analyzer (Applied Biosystems).
Results
B6.apoE Ϫ/Ϫ mice developed prominent neointimal lesions in the common carotid artery 4 weeks after endothelial denuda- tion injury when fed the Western diet ( Figure 1 ). In contrast, neointimal lesions were barely detectable in C3H.apoE Ϫ/Ϫ mice. Immunohistochemical analysis with specific antibodies against smooth muscle cells and macrophages revealed that smooth muscle cells were the primary cellular component of neointimal lesions and a few focally accumulated macrophages were present in the peripheral region of the lesions. To determine genetic factors contributing to variation in neointimal lesion size, we performed QTL analysis using an intercross between the 2 apoE Ϫ/Ϫ strains. Two hundred four male F 2 mice were analyzed for such phenotypes as neointimal lesion size, plasma lipid and MCP-1 levels 4 weeks after arterial injury and were genotyped for microsatellite markers spanning the entire genome. As shown in Figure 2 , the values of plasma non-HDL cholesterol, triglyceride, and MCP-1 levels in F 2 mice are approximately normally distributed. The normal distribution parameters obtained by examining skewness, kurtosis, Kolmogorov-Smirnov test, and Q-Q plot . Likelihood plots for neointimal lesion size on chromosome 12 and chromosome 13. Plots were generated using the interval mapping function of Map Manager QTX, including a bootstrap test shown as a histogram estimating the confidence interval of a QTL. Vertical green lines on the plot represent significance thresholds for the likelihood-ratio statistic, indicating "suggestive (Pϭ0.63)," "significant (Pϭ0.05)," or "highly significant (Pϭ0.01)" peaks as calculated by permutation analysis for the genome-wide significance thresholds. Black plots reflect the likelihood-ratio statistic calculated at 1-cM intervals. The red plot represents the additive regression coefficient, and the blue plot represents the dominant regression coefficient, indicating effect of the B6 allele. SI indicates support interval. *LOD scores were generated with J/qtl software. "Suggestive" or "significant" QTLs were calculated by 1000 permutation tests, and the corresponding genome-wide significance thresholds were Pϭ0.63 and Pϭ0.05, respectively. The significant loci are italicized to easily distinguish them from suggestive loci. †SIs were defined by a 1-unit decrease in LOD score on either side of the peak. ‡Variance (%), which indicates the percentage of the phenotypic variance detected in the F 2 cohort under the peak marker, was generated with MapManager QTX program.
§Model of inheritance was determined by using the MapManager QTX program and further confirmation was made for loci at which heterozygotes exhibited significantly higher or lower trait values than both homozygotes by performing linear regression using the additive and dominant/recessive models.
indicated that the values of square root-transformed lesion sizes of F 2 mice approached a normal distribution.
A genome-wide scan with F 2 mice revealed that a significant QTL on chromosome 12 and a suggestive QTL on chromosome 13 influenced neointimal lesion size (Figure 3) . Details of the QTL detected, including peak marker locus, LOD score, support interval, variance, and mode of inheritance, are presented in Table 1 . The chromosome 12 locus peaked near marker D12Mit144 (61 cM, LOD: 5.02) and explained 15% of the variance in lesion size of the cross (Figure 4 ). We designated this QTL as Nih1 to represent the first QTL detected that affects neointimal lesion size in the mouse. This locus exhibited a dominant inheritance pattern in that F 2 s with the heterozygous BC genotype at peak marker D12Mit144 had a lesion size comparable with F 2 s with the homozygous BB genotype but larger than those homozygous in the CC genotype (Pϭ1.27ϫ10 Ϫ5 ; Table 2 ). The chromo-some 13 locus peaked near D13Mit250 (35 cM) and had a suggestive LOD score of 2.67 ( Figure 4 , Table 1 ). This locus explained 8% of the variance in lesion size and exhibited a dominant effect from the B6 allele on the trait ( Table 2) .
As shown in Figure 5 and Table 1 , plasma non-HDL cholesterol and triglyceride levels were each influenced by 2 or more QTL. A QTL on distal chromosome 1 near D1Mit270 (92.3 cM) had significant LOD scores of 3.31 for non-HDL and 4.92 for triglyceride and explained 9% and 11% of the variance in the traits, respectively. A significant QTL on chromosome 12 near D12Mit97 (47 cM) had a significant LOD of 4.0 and accounted for 9% of the variance in non-HDL cholesterol levels. This QTL overlapped with Nhdlq12, recently mapped in a female BXH F 2 cross. 13 A suggestive QTL for non-HDL near D4Mit192 (6.3 cM; LOD: 2.18) corresponded to Chol8, identified in a 129S1/SvImJXCAST/Ei intercross, 14 and a QTL near D7Mit330 (57.5 cM, LOD: 2.13) corresponded to Chldq4, mapped in a MRL/MpJXSJL/J intercross. 15 The QTL near D15Mit161 for non-HDL (69.2 cM, LOD: 2.08) and the QTL near D16Mit165 (10.3 cM, LOD: 2.7) for triglyceride are novel. Four suggestive loci, located on chromosomes 1, 2, and 3, were detected to affect plasma MCP-1 levels of F 2 mice ( Table  1 ). The chromosome 1 locus near D1Mit102 (73 cM) had a suggestive LOD score of 2.59 and explained 5% of the variance in MCP-1 levels. The chromosome 2 locus near D2Mit263 (92 cM) had a LOD score of 2.06 and explained 4% of the variance. The chromosome 3 loci, peaked near D3Mit21 (19.2 cM, LOD: 2.21) and D3Mit230 (38.3 cM, LOD: 2.17), respectively, each accounted for 4% of the variance in MCP-1 levels.
The NCBI and the Mouse Phenome databases were queried to identify sequence differences underlying Nih1 that lead to changes in either the structure or quantity of a gene product between B6 and C3H mice. Twenty-two nonsynonymous single-nucleotide polymorphisms (SNPs) were detected in 10 and 4 gene sequences (RIKEN cDNA or expressed sequences) and 41 SNPs were detected in the regulatory regions of 12 genes and 7 gene sequences. The genes containing nonsynonymous SNP or/and SNP in regulatory regions were further examined for their expression in the arterial wall of the 2 strains. Three functional candidates, including Tnfaip2, Crip2, and Itgb8, were also evaluated by real-time PCR, although their sequence information was unavailable for C3H. As shown in Table 3 , Yy1 was highly expressed in C3H, Pacs2 highly expressed in B6, Traf3, Cdc42bp, Tnfaip2, Klc1, Kif26a, Inf2, Pld4, Akt1, Gpr132, Jag2, Mta1, Crip2, and Itgb8 similarly expressed in both strains, and several other genes, including Chga, Bdkrb2, Adam6, Ptprn2, and Cdca7l, were barely detectable. Bag5 and Siva1 were also differentially expressed in the 2 strains when the original ⌬ct values (target gene-Gapdh cycle threshold) were analyzed (supplemental Table I ). Yy1, Bag5, Siva1, and Pacs2 were further evaluated by real-time PCR using RNA extracted from the uninjured carotid arteries ( Table 4 ). The trend of differences between the 2 strains in gene expression levels was comparable in the aorta and carotid arteries. A search of the NCBI Gene Expression Omnibus database (http://www. ncbi.nlm.nih.gov/geo/) reveals that Yy1, Bag5, Siva1, and Pacs2 are expressed in the aortic wall of C57BL/6 and C3H mice (accession No. GDS735, GSE14854, GSE1560). Interestingly, a microarray study using RNA extracted from the aorta of B6.apoE Ϫ/Ϫ and C3H.apoE Ϫ/Ϫ mice also shows higher Yy1 and Bag5 expression in C3H (GSE14854).
Immunohistochemical analysis confirmed the expression of Yy1 and Pacs2 in the arterial wall and neointimal lesions ( Figure 6 ). For Yy1, the uninjured carotid artery was more intensely stained in C3H than in B6, whereas the inner layer Gene expression levels are expressed as copy number of candidate gene mRNA relative to 1000 copies of GAPDH mRNA. Results are meanϮSD of 3 to 4 biologically independent samples for each strain. Total RNA was prepared from the aorta of 6-to 10-week-old mice fed a chow diet.
NQ indicates expression level too low to accurately quantify; CN, coding nonsynonymous polymorphism resulting in amino acid substitution; Reg, regulatory region; ?, sequence information unavailable.
of neointimal lesions was more intensely stained in B6 than in C3H. Pacs2 showed endothelial staining in the uninjured artery but diffuse staining of the medial layer and neointimal lesions in the injured artery. We sequenced the promoter region of the Yy1 gene for B6 and C3H mice and found 5 SNPs (ϪA1445G, ϪA1443C, ϪC1435A, ϪA1354C, and ϪG1304T) and a 10-bp deletion (Ϫ1351 to Ϫ1342: TTTTTAAATA) in C3H (Figure 7 ).
Discussion
B6.apoE Ϫ/Ϫ and C3H.apoE Ϫ/Ϫ mice exhibit marked differences in neointimal formation following the carotid endothelium denudation injury when fed a Western diet. In this study, we performed QTL analysis using an intercross derived from the 2 apoE Ϫ/Ϫ strains to search for genetic factors contributing to neointimal formation and associated traits. We identified one significant QTL on chromosome 12 and one suggestive QTL on chromosome 13 for neointimal lesions, replicated 7 QTLs for plasma lipids, and detected 4 suggestive QTLs for circulating MCP-1.
Inbred strains B6 and C3H are prototype mouse models for genetic studies of atherosclerosis. B6 mice readily develop atherosclerosis whereas C3H mice are resistant when fed an atherogenic diet or deficient in apoE. 16, 17 Using intercrosses derived from the 2 strains, we and others have identified several QTLs contributing to the development of atherosclerosis. 12,18 -20 However, the study of various mouse strains has shown that genetic susceptibility to injury-induced neointimal hyperplasia is distinct from susceptibility to atherosclerosis as strains susceptible to atherosclerosis are resistant to neointimal hyperplasia and vice versa. 21 Thus, genetic factors identified for atherosclerosis might not reflect genetic control of neointimal hyperplasia. ApoE Ϫ/Ϫ mice represent an animal model in which spontaneous hyperlipidemia and atherosclerosis occur on a low fat, low cholesterol diet. Because most restenosis patients have a history of hyperlipidemia and atherosclerosis, apoE Ϫ/Ϫ mice are obviously a more suitable model for the study of restenosis than wild-type mice. In this study, using a F 2 cross derived from the 2 apoE Ϫ/Ϫ strains, we identified a significant QTL, named Nih1, on distal chromosome 12 and a suggestive QTL on chromosome 13 that affected neointimal lesion size. The chromosome 12 QTL mapped to the distal region (61 cM), and the B6 allele conferred the increased neointimal lesion formation at the locus. This locus did not overlap with any atherosclerosis QTLs mapped in genetic crosses derived from B6 and C3H mice, 12,13,18 -20 suggesting that neointimal hyperplasia and atherosclerosis are controlled by separate genetic factors. Indeed, the pathology of these 2 vascular disorders is quite different: the neointimal lesion consists largely of vascular smooth muscle cells, although macrophages are also present (Figure 1) , whereas macrophages are the major cellular component of atherosclerotic lesions at all stages and smooth muscle cells only become prominent in the advanced stage. 22 B6 and C3H are among the inbred mouse strains whose whole genome sequences and genetic variants have been well characterized. Thus, we perused all genes within the confidence interval of Nih1 to detect sequence variants that may contribute to the quantitative trait. Flint et al 23 have analyzed 20 cloned QTL genes in rodents and found that all of them have sequence variations in coding or regulatory regions leading to changes in structure, quantity, or both of a gene product. One probable candidate for Nih1 is Yy1, a ubiquitous and zinc finger transcription factor. Expression of this gene results in inhibition of neointima growth in human, rabbit, and rat blood vessels. 24 We found that Yy1 expression levels in uninjured arterial walls were higher in C3H than in B6 by real-time PCR and immunohistochemistry. A higher expression of Yy1 by arterial wall cells would lead to a greater inhibition of neointimal formation in C3H. The strong ex- TABLE) . These 4 genes were further evaluated by real-time PCR using RNA extracted from the uninjured carotid arteries of 6-to 10-week-old mice fed a chow diet. Gene expression levels are expressed as copy number of candidate gene mRNA relative to 1000 copies of GAPDH mRNA. Results are meanϮSD of 4 biologically independent samples for each strain. pression of Yy1 by proliferating neointima might also regulate its growth. We identified a 10-bp deletion and 5 SNPs in the promoter region of Yy1, which could be responsible for the higher baseline expression in C3H. Other probable candidates in the region are 3 apoptosis-related genes, including Bag5, Siva1, and Pacs2. Apoptosis or programmed cell death of vascular smooth muscle cells plays a critical role in injury-induced neointimal hyperplasia. 25 These 3 genes exhibited nonsynonymous polymorphisms between B6 and C3H and were differentially expressed in the arterial wall of the 2 strains.
In this study, we found that QTL on distal chromosome 1 contributed to variations in plasma non-HDL cholesterol and triglyceride levels in the F 2 cross. This finding is consistent with previous observations made with female F 2 crosses between B6.apoE Ϫ/Ϫ and C3H.apoE Ϫ/Ϫ mice. 12, 13 Hyperlipidemia has been considered responsible for aggravated neointimal formation of apoE Ϫ/Ϫ or LDLR Ϫ/Ϫ mice on a Western diet. 10, 11 However, the present study of F 2 mice has demonstrated that neointimal formation is independent of plasma lipid levels in that the size of neointimal lesions was not correlated with plasma non-HDL cholesterol or triglyceride levels (data not shown). A previous observation that B6.apoE Ϫ/Ϫ mice developed 5-fold larger neointimal lesions than C3H.apoE Ϫ/Ϫ mice despite their comparable levels of plasma low-density lipoprotein, or low-density lipoprotein and HDL cholesterol on a chow diet 10 also suggests that factors other than plasma lipids contribute to differential neointimal formation of the B6 and C3H strains.
In this study, we detected 4 suggestive QTLs that influenced plasma levels of MCP-1 in apoE Ϫ/Ϫ mice, although none of them overlapped with neointimal lesion QTLs. MCP-1 is the prototypical CC chemokine that is induced by noxious stimuli such as oxidized low-density lipoprotein, endotoxin, and mechanical forces in a variety of cells, including smooth muscle cells, endothelial cells, macrophages, and fibroblasts. We previously observed a distinct difference between B6 and C3H mice in the induction of MCP-1 by oxidized low-density lipoprotein in arterial wall cells. 17, 26 Because MCP-1 functions in the recruitment of monocytes, the expression of this proinflammatory molecule by vascular wall cells is expected to lead to monocyte recruitment to injured arterial walls and promote neointimal formation. However, the present study of F 2 mice has suggested a less significant role for this chemokine in differential neointimal growth of the B6 and C3H strains because the size of neointimal lesions was not correlated with MCP-1 levels.
In summary, this study has identified the first significant QTL for neointimal hyperplasia, which does not overlap with loci for atherosclerotic lesions identified from previous crosses derived from the same parental strains. Moreover, we found no correlations between neointimal lesion size and plasma lipid levels or between lesion size and plasma MCP-1 levels. Thus, our findings indicate that neointimal formation is controlled by genetic factors independent of those affecting plasma lipid levels and circulating MCP-1 levels in hyperlipidemic mice.
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